Chief Executive Officer and Managing Director of Ranbaxy Malvinder Mohan Singh (L) shakes hands with President and Chief Executive Officer of Daiichi Sankyo Takashi Shoda (R) during a press conference in New Delhi, India
1 of 1
Chief Executive Officer and Managing Director of Ranbaxy Malvinder Mohan Singh (L) shakes hands with President and Chief Executive Officer of Daiichi Sankyo Takashi Shoda (R) during a press conference in New Delhi, India. Japan`s third largest drug maker, Daiichi Sankyo Co. announced Friday it has successfully completed the takeover of India`s top generic drug maker Ranbaxy Laboratories Ltd in a deal valued at $4.2 billion. (AFP Photo)